---
title: "Clover Health Investments, Corp. 2Q 2026: Revenue $743.2M, EPS $0.05— 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295233144.md"
description: "Clover Health reported Q2 2026 revenue of $743.2M, up 55.6% YoY, driven by 50% membership growth and higher PMPM rates. Net income turned positive at $28M, with diluted EPS of $0.05 versus a loss last year. Average Medicare Advantage membership reached ~156K across 203 counties. Operational metrics improved, including adjusted EBITDA and lower SG&A ratios. Star ratings for 2027 were upgraded to 4.5."
datetime: "2026-08-07T12:11:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295233144.md)
  - [en](https://longbridge.com/en/news/295233144.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295233144.md)
generator: "portal-rs"
---

# Clover Health Investments, Corp. 2Q 2026: Revenue $743.2M, EPS $0.05— 10-Q Summary

Clover Health Investments, Corp. reported second-quarter 2026 results with revenue of $743.2M and net income of $28M, versus $477.6M revenue and a $(10.6) M loss in the year-ago quarter; diluted EPS was $0.05 compared with $(0.02) a year earlier.

**Financial Highlights**

-   Revenue was $743.2M for Q2 2026, up from $477.6M in the year-ago quarter; YoY change 55.6%.
-   Net income was $28.0M for Q2 2026, versus a loss of $(10.6) M in the year-ago quarter.
-   Diluted EPS was $0.05 for Q2 2026, versus $(0.02) in the year-ago quarter.

**Business Highlights**

-   Total revenues rose roughly 56-59% year over year, driven by about 50% membership growth and higher per-member-per-month (PMPM) rates.
-   Average Medicare Advantage membership grew about 49-50% to roughly 156K members; the company's footprint expanded to 203 counties.
-   Income from operations turned positive, with $28M in the quarter and $55M year-to-date, alongside improved Adjusted EBITDA.
-   Adjusted SG&A as a percentage of revenue improved (18% to 16% year-to-date) as revenue scaled faster than administrative costs.
-   Quality ratings improved, with PPO/HMO Star ratings uplift to 4.5 Stars for the 2027 recalculation, expected to affect future payments.

Original SEC Filing: CLOVER HEALTH INVESTMENTS, CORP. /DE \[ CLOV \] - 10-Q - Aug. 07, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CLOV.US](https://longbridge.com/en/quote/CLOV.US.md)

## Related News & Research

- [Clover Health releases transcript of 2Q26 supplemental Q&A on earnings call](https://longbridge.com/en/news/296533818.md)
- [AIIR: H1'26 saw resilient revenue and stable Adjusted EBITDA amid disruption, with growth set to accelerate](https://longbridge.com/en/news/296476265.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Axian Telecom releases Q2 2026 results presentation](https://longbridge.com/en/news/296807653.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**